|
|
|
Latest News
|
|
Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute
A multinational pharmaceutical corporation sued a generic manufacturer for filing an Abbreviated New Drug Application (ANDA) that sought approval to manufacture, use, and sell a generic kidney cancer treatment drug before the expiration of its patents. The defendant approached WIT to support their expert witness needs.
|
|
|
|
|
|
|
WIT Has the Best Experts to Support Parties Involved in Hatch-Waxman Litigation
|
|
|
|
|
|
|
More Top Insights
|
|
2023 in Review: Key ITC Insights Report
While 2023 was a down year in terms of instituted 337 Investigations, we believe it was an outlier with significant reason to reassess the viability and effectiveness of the ITC for 2024. Download the report.
|
|
|
Want to learn more about our expert teams?
|
|
|
|
|
|
Events
|
|
|
ACI’s 20th Annual Paragraph IV Disputes Conference – April 25-26, 2024, NYC
|
|
Join WIT at ACI’s 20th Annual Paragraph IV Disputes Conference. This year’s event will celebrate the 40th Anniversary of the Hatch-Waxman Act and take a retrospective look at the impactful court cases, pivotal legislation, and industry shifts that have defined the patent endgame and the pursuit of profits.
|
|
Learn More
|
|
|
|
|
|
About WIT
|
|
WIT is the leading agency representing testifying experts in legal disputes involving advanced technologies and life sciences. We focus on industries with increased risk of litigation and build expert teams comprised of world-class academics, industry executives, and former government regulators. Partnering with WIT assures that you engage with testifying experts who have been selected for their knowledge, experience, and ability to communicate effectively.
|
|
WITlegal.com
|
|
|
